⌘K

Home/Filings/4/0001171843-15-003572

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-15-003572

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 3:15 PM ET

Size

7.5 KB

Accession

0001171843-15-003572

Insider Transaction Report

Form 4

Period: 2015-06-19

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Award
Stock Option (Right to Buy)
2015-06-19+200,000→ 1,168,000 total
Exercise: $0.25From: 2015-06-19Exp: 2025-06-19→ Common Stock (200,000 underlying)
Award
Stock Option (Right to Buy)
2015-06-19+50,000→ 968,000 total
Exercise: $0.25From: 2015-06-19Exp: 2025-06-19→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]50% immediately vested and 50% to vest monthly over 12 month-period

Documents

1 file

4
gff4_holliman062315.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 3:15 PM ET
Size: 7.5 KB

View on SEC.gov